Published source snapshot
NooCamilon Picamilon 50
LifeLink · US label facts
Label IDlbl_dsld_11772_7c3cece1f69d5024
Serving size1 Capsule(s)
Serving formCapsule(s)
Retrieved
Scope: source-market status describes the source record, not live availability. Quantities below are label facts and deterministic arithmetic, not a product recommendation.
Original facts and normalized results
| Ingredient | Original label quantity | Requested normalization | Measurement object |
|---|---|---|---|
| Picamilon DSLD row path: root.0; DSLD ingredientId: 21425 | 50 mg | 50 mg / as_labeled | Picamilon |
| Cellulose Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 28392. | Not stated | missing_quantity | Microcrystalline Cellulose |
| Gelatin Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 3715. | Not stated | missing_quantity | Gelatin |
Label statements
These are explicitly classified as label claims. They are not converted into platform-endorsed scientific conclusions.
- label_claim FDA Statement of Identity: DIETARY SUPPLEMENT
- label_claim General Statements: All Other Content: Picamilon is a nutraceutical developed in Russia for improving mood, learning, memory, vision, and other neurological functions. See our website for details: www.lifelinknet.com/siteResources/Products/NooCamilon.asp
- label_claim Suggested/Recommended/Usage/Directions: Suggested Use: 1-4 capsules daily in divided doses or as directed by a health care professional.
Ingredient references
Reference pages provide verified source mappings. Unless a real review record exists, they remain reference-only with no medical summary or evidence grade.
Source and version
- Original record
- NIH ODS DSLD label 11772
- Local snapshot
- snap_dsld_11772_7c3cece1f69d502418fd7180
- Content hash
7c3cece1f69d502418fd7180e2b55a7372a6b21d9008271f678b2ea1b62c8427- Source version
- Not stated
Limitations
- This record reports label facts from a US-market source snapshot, not current inventory or product safety.
- Label quantity comparisons do not establish absorption, efficacy, safety, or clinical equivalence.